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Elution is a procedure for recovery of antibody attached to intact, 
immunoglobulin-coated red blood cells (RBCs) by disrupting the 
antigen–antibody bonds. The recovered antibody is collected 
in an inert diluent and is referred to as an eluate. Testing of an 
eluate may be desired to identify antibody(ies) coating the RBCs 
of patients with a positive direct antiglobulin test. Many types of 
elution procedures have been developed and described; however, 
an acid elution is suitable for antibody recovery in most cases, such 
as recovery of alloantibodies and warm-reactive autoantibodies. 
Studies have compared methods such as xylene, chloroform, 
digitonin acid, dichloromethane, citric acid, and Immucor Elu-Kit 
II (cold acid elution). The ELU-Kit II has been shown to be quick 
and effective at eluting a wide range of alloantibodies as well as 
autoantibodies without the use of hazardous chemicals or costly 
reagent preparation time that some methods use. It is for these 
reasons that the ELU-Kit II is a very popular method for the elution 
of immunoglobulin G (IgG) antibodies. Immunohematology 
2014;30:113–116.
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Elution is a procedure for recovery of antibody attached 
to intact, immunoglobulin-coated red blood cells (RBCs) 
by disrupting the antigen–antibody bonds.1 The recovered 
antibody is collected in an inert diluent and is referred to as 
an eluate.2 Testing of an eluate may be desired to identify 
antibody(ies) coating the RBCs of patients with a positive direct 
antiglobulin test (DAT).3 Many types of elution procedures 
have been developed and described; however, an acid elution is 
suitable for antibody recovery in most cases, such as recovery 
of alloantibodies and warm-reactive autoantibodies.4 Studies 
have compared methods such as xylene, chloroform, digitonin-
acid, dichloromethane, citric acid, and Immucor Elu-Kit II 
(cold acid elution).1,3,5 The ELU-Kit II has been shown to be 
quick and effective at eluting a wide range of alloantibodies as 
well as autoantibodies without the use of hazardous chemicals 
or costly reagent preparation time that some methods use.5 
It is for these reasons that the ELU-Kit II is a very popular 
method for the elution of immunoglobulin G (IgG) antibodies.
Principle
For an antibody to be effectively eluted from RBCs, the 
antigen–antibody complexes must be disturbed by reversing 
or neutralizing the binding forces. This can be accomplished 
by altering the pH of the solution.1
RBCs coated with IgG antibody are first thoroughly 
washed with saline or a buffered wash solution to remove 
all unbound protein while maintaining the associated bound 
antibody without lysing the RBCs. The washed RBCs are 
suspended in a low pH glycine-HCl solution to dissociate the 
bound antibody. After centrifugation to separate the RBCs from 
Reagents/Supplies
Reagents Supplies
• Concentrated wash solution
• Eluting solution
• Buffering solution
• Isotonic saline or phosphate-
buffered isotonic saline (pH 
6.5–7.5)
• Anti-human globulin containing 
anti-IgG
• IgG-sensitized red blood cells
• Polyethylene glycol additive 
(optional)
• 12- × 75-mm test tubes
• Stopper/caps for tubes
• Pipettes (glass or plastic)
• Centrifuge





• Wash RBCs one time with saline and four times with working wash 
solution
• Reserve an aliquot of the last wash supernatant for use as a control 
in testing
• Place 1 mL (approximately 20 drops) of washed RBCs in a clean, 
labeled test tube
• Add an equal amount of eluting solution
• Cap the tube and gently invert four times
• Immediately centrifuge 45–60 seconds
• Transfer supernatant to a clean, labeled tube
• Add sufficient buffering solution to restore the pH of the eluate 
(indicated by a pale blue color)
• Mix well and centrifuge
Testing the Eluate
• Add 1 drop washed RBC suspension or commercial reagent RBC 
to labeled test tube
• Add a small volume of saline, mix, and centrifuge
• Decant saline and blot dry
• Add 2 drops of eluate, mix, and incubate 10–30 minutes at 37°C
• Wash cells one time with working wash solution
• Centrifuge, decant working wash solution, and blot dry
• Add anti-IgG, mix, centrifuge, and read
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the dissociated antibody, the antibody-containing supernatant 
is then neutralized back to a normal pH with a buffering 
solution. The remaining eluate may then be tested by a method 
appropriate for detection of IgG antibodies.1 The eluate should 
be tested in parallel with an aliquot of supernatant from the 
final wash of the RBCs to ensure that antibody detected in 
the eluate is RBC-bound antibody and not residual plasma 
antibody.4
Indications
Eluates may be prepared and tested to identify 
antibody(ies) on the RBCs of patients with a positive DAT 
caused by autoantibodies or alloantibodies. Elution studies 
are an important component to the laboratory diagnosis of 
immune-mediated RBC destruction caused by alloantibodies, 
autoantibodies, and drug-induced phenomena. In patients who 
have received RBC transfusion in the previous 3 to 4 weeks and 
develop a positive DAT, eluate testing can be very important in 
identifying newly developing antibodies or delayed hemolytic 
transfusion reactions.6 Eluates can be prepared from RBCs 
coated with antibody in vivo or in vitro. When used in 
combination with in vitro adsorption techniques, elutions 
may also be desired to confirm the presence or absence of a 
weakly expressed antigen on RBCs, to isolate a single antibody 
specificity from a plasma containing multiple alloantibodies, 
or to concentrate antibody-containing solutions.1
Procedure
Preparing the Eluate1
RBCs should be washed thoroughly until the supernatant 
is free of hemolysis using saline or working wash solution 
(ELU-Kit II). If the working wash solution is to be used, 
wash the RBCs one time with saline followed by four washes 
with the working wash solution. It is recommended that the 
washing be performed using saline or working wash solution 
chilled to 1° to 10°C to minimize the loss of bound antibody. 
Reserve an aliquot of the last wash supernatant for use as a 
control in testing.
Place 1 mL (or approximately 20 drops) of washed RBCs 
in a clean 12- × 75-mm test tube. If there is an insufficient 
amount of RBCs to yield 1 mL of cells, a smaller volume of 
RBCs may be used. Add an equal amount of eluting solution to 
the tube containing the RBCs, cap, and gently invert the tube 
four times. To prevent hemolysis, immediately centrifuge the 
tube 45 to 60 seconds, and transfer the supernatant to a clean 
tube.
To the tube containing the acidic eluate, add 1 mL of 
buffering solution or an amount equal to the volume of RBCs 
used for eluting. As the pH is restored to the range acceptable 
for testing (6.4 to 7.6), the color of the solution should change 
from yellow to a pale blue. If the eluate remains yellow after 
20 drops of buffering solution has been added, continue to add 
buffering solution dropwise until a pale blue color persists. 
Mix well and centrifuge to remove any precipitate that 
formed during neutralization, and transfer the supernatant 
to a clean, properly labeled tube. The eluate may now be 
tested by a desired indirect antiglobulin method for antibody 
identification.
Testing the Eluate
Potentiators such as bovine albumin or low-ionic-strength 
saline are not usually necessary because the eluate has been 
prepared in a low-ionic substrate. If the use of polyethylene 
glycol (PEG) additive is desired to enhance the antibody 
reactivity, the modified antiglobulin test should not be used.1 
Some studies have shown that eluates can be effectively tested 
using gel microcolumn assay or solid-phase red cell adherence 
assay7; however, these methods should be validated by 
individual laboratories before routine use.
Add one drop of washed RBC suspension or commercial 
reagent RBCs to a labeled test tube. Add a small volume 
of saline (5–10 drops), mix thoroughly, and centrifuge 30 
seconds. Decant the saline supernatant and blot the tube dry.1
Add two drops of the eluate to the dry cell button, mix 
thoroughly, and incubate at 37°C ± 1°C for 10 to 30 minutes. 
If PEG enhancement is added, follow the manufacturer’s 
instructions for incubation time.1
After incubation, add 5 to 10 drops of working wash 
solution to the tube, mix thoroughly, and centrifuge for 30 
seconds. Decant the working wash solution supernatant and 
blot the tube dry. This method is referred to as the modified 
antiglobulin test. If PEG was used in the test system, the 
modified antiglobulin test should not be performed; instead, 
the RBCs should be washed at least three times with saline 
before adding anti-IgG. It is not necessary to wash the tube 
containing PEG using the working wash solution. Add anti-
IgG as directed to the dry cell button, mix, and centrifuge. 
Examine the tube for agglutination and record results. IgG-
sensitized RBCs should be added to all negative antiglobulin 
tests to confirm anti-IgG was added to the test system and to 
thus validate the test results.1
The last wash supernatant should be tested for antibody 
reactivity in parallel with the eluate to ensure that antibody 
identified in the eluate is not a result of inadequate washing of 
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the RBCs.1 There should be no antibody reactivity detected in 
the last wash control tubes.
Quality Control
An aliquot of the last wash supernatant should be retained and 
tested in parallel with the eluate. Negative results should be 
obtained in the last wash control testing to demonstrate that 
the reactivity observed in the eluate is not unbound antibody 
in suspension as a result of inadequate washing of the red 
blood cells before the elution process. If reactivity is observed 
with the last wash control, the elution procedure should be 
repeated after more thorough washing of the RBCs.1,8
Limitations
If antibody reactivity is detected in the last wash control, 
the eluate results should be considered invalid and all steps 
should be repeated. Antibody reactivity detected in the last 
wash may be caused by inadequate washing of the RBCs or 
may be owing to dissociation of the antibody from the RBCs 
during the washing process. To minimize the amount of 
antibody dissociation that occurs during washing of the RBCs, 
washing the RBCs with cold (1–10°C) working wash solution 
before elution may be beneficial.1
A nonreactive eluate prepared from RBCs demonstrating 
a positive DAT can indicate the presence of drug-dependent 
antibodies, nonimmunologic uptake of IgG onto the RBCs, or 
possibly an antibody to a low-prevalence antigen not present 
on panel cells tested.6
RBCs that have been used for this elution process must be 
discarded and should not be used for testing, such as antigen 
typing or autoadsorption. Acid elution procedures do not 
significantly reduce the strength of the DAT, which renders 
the RBCs unsuitable for phenotyping. If antigen typing or 
autoadsorption is desired, another elution method (such as one 
that uses citric acid) should be used.3
RBCs that have been stored for longer than 72 hours 
may produce less potent eluates when compared with eluates 
prepared from freshly drawn samples. A different elution 
method may be more effective for preparing an eluate from 
RBCs with prolonged storage.1
Hemolysis of RBCs may occur if there is prolonged contact 
with the eluting solution. The RBCs must be centrifuged 
immediately after addition of the eluting solution and the 
supernatant transferred to a clean test tube.1
Hemolysis of RBCs may also occur if the pH of the eluate 
is not restored to neutral pH range before testing. This may 
result in false-negative results.1
False-positive results may occur with the use of the 
working wash solution as a result of the presence of a 
nonspecific high-titer antibody. In this case, saline should be 
used as a substitute for washing the RBCs before the addition 
of eluting solution.1
False-negative results may occur with use of the modified 
antiglobulin test if the test RBC suspension is not thoroughly 
washed to remove all human protein. Use of IgG-sensitized 
RBCs will assure that this has not occurred if a positive 
result is obtained after addition of the IgG-sensitized RBCs. 
A negative result after addition of IgG-sensitized RBCs should 
alert the tester to this possible source of error.1
Consideration may be given to selecting an elution method 
that yields a more potent eluate than other methods for certain 
antibody specificities. For example, the ELU-Kit II method 
yields more demonstrable anti-e than the chloroform, digitonin 
acid, or dichloromethane methods. However, the ELU-Kit II 
method has been shown to be less effective at recovering anti-
Jkb than other methods.5
Performance of antibody elutions as a result of a positive 
DAT caused by IgG should be reserved for those patients who 
have been recently transfused or are suspected of having 
immune-mediated hemolysis. Studies have shown that the 
routine performance of antibody elutions on all patients with 
a positive DAT is not clinically useful because the majority of 
positive DATs yield negative eluates and, of those that yield 
positive reactivity, the majority of the eluted antibodies are 
also demonstrable in the serum.9,10
Summary
The Gamma ELU-Kit II is an effective method for the rapid 
acid elution of antibodies from intact RBCs. However, there 
is no single elution method that is ideal for every situation. 
If an eluate prepared by cold acid elution (ELU Kit II) gives 
inconclusive results, it may be beneficial to prepare an eluate 
by a different method.
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